Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets.
Global Alpha Emitter Market is valued approximately at USD 751.7 million in 2021 and is anticipated to grow with a healthy growth rate of more than 38.31% over the forecast period 2022-2029. Alpha emitters are useful in the therapy of cancer. The properties of alpha emitters have resulted in significant differences between this discipline and other nuclear medicine specialties. Alpha particles have been widely used in medical studies due to their limited range and high LET (deposit energy per unit length of route). Ovarian cancer, pancreatic cancer, lymphoma, and melanoma are among of the malignancies that are treated using alpha emitters. The treatment method employs a variety of radionuclides, including radium, lead, and bismuth. Increased awareness of the potential advantages of targeted alpha treatment, as well as the rising number of patients with cardiac and cancer diseases, are driving market growth. Furthermore, the growth is due to an increase in the number of new diagnostic cases. According to the American Cancer Society, around 22,240 women are projected to be diagnosed with ovarian cancer in 2018, with approximately 14,070 women dying from the disease. In addition, At-211-MX35 F (ab′) showed significant effectiveness in a recent Phase I clinical trial, with therapeutic doses reaching their goals in patients with ovarian cancer. However, stringent regulatory framework and reimbursement issues may impede market growth over the forecast period of 2022-2029.
North America currently dominates the alpha emitter market, and it is projected to remain so for a few more years. The increase in cardiac and neurological chronic illnesses, which is the primary driving reason for market growth in the region. For example, 223RaCl2 (Xofigo) is the first alpha emitting radioisotope to be approved for palliative treatment of prostate cancer bone metastases by indirect physiological targeting in the United States.
Major market player included in this report are:
Alpha Tau Medical Ltd
Actinium Pharmaceuticals Inc.
IBA Radiopharma Solutions
Telix Pharmaceuticals Ltd
Fusion Pharmaceuticals
RadioMedix Inc.
Bayer AG.
Recent Developments in the Market:
In November 2021, RadioMedix awarded USD 2 million grant to support Phase I/II clinical development of the innovative alpha-emitter labeled peptide, AlphaMedix, for therapy of somatostatin receptor-positive neuroendocrine tumors.
Global Alpha Emitter Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type of Radionuclide, Medical Application Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type of Radionuclide:
Astatine (At-211)
Radium (Ra-223)
Actinium (Ac-225)
Lead (Pb-212)
Bismuth (Bi-212)
Other Type of Radionuclides
By Medical Application:
Prostate Cancer
Bone Metastasis
Ovarian Cancer
Pancreatic Cancer
Endocrine Tumors
Other Medical Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Leather Goods Market, by Region, 2019-2029 (USD Billion)
1.2.2. Leather Goods Market, by Type, 2019-2029 (USD Billion)
1.2.3. Leather Goods Market, by Product, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Leather Goods Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Leather Goods Market Dynamics
3.1. Leather Goods Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising fashion trend towards leather
3.1.1.2. Surging demand for luxury leather goods
3.1.2. Market Challenges
3.1.2.1. Stringent government regulations
3.1.3. Market Opportunities
3.1.3.1. Rising inclination towards vegan and synthetic leather
3.1.3.2. Growing domestic & international tourism
Chapter 4. Global Leather Goods Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Leather Goods Market, by Type
6.1. Market Snapshot
6.2. Global Leather Goods Market by Type, Performance – Potential Analysis
6.3. Global Leather Goods Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Leather Goods Market, Sub Segment Analysis
6.4.1. Genuine
6.4.2. Synthetic/Vegan
Chapter 7. Global Leather Goods Market, by Product
7.1. Market Snapshot
7.2. Global Leather Goods Market by Product, Performance – Potential Analysis
7.3. Global Leather Goods Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
7.4. Leather Goods Market, Sub Segment Analysis
7.4.1. Handbags
7.4.2. Small leather goods & accessories
7.4.3. Apparel
7.4.4. Footwear
7.4.5. Pet accessories
7.4.6. Automotive accessories
Chapter 8. Global Leather Goods Market, Regional Analysis
8.1. Leather Goods Market, Regional Market Snapshot
8.2. North America Leather Goods Market
8.2.1. U.S. Leather Goods Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Product breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Leather Goods Market
8.3. Europe Leather Goods Market Snapshot
8.3.1. U.K. Leather Goods Market
8.3.2. Germany Leather Goods Market
8.3.3. France Leather Goods Market
8.3.4. Spain Leather Goods Market
8.3.5. Italy Leather Goods Market
8.3.6. Rest of Europe Leather Goods Market
8.4. Asia-Pacific Leather Goods Market Snapshot
8.4.1. China Leather Goods Market
8.4.2. India Leather Goods Market
8.4.3. Japan Leather Goods Market
8.4.4. Australia Leather Goods Market
8.4.5. South Korea Leather Goods Market
8.4.6. Rest of Asia Pacific Leather Goods Market
8.5. Latin America Leather Goods Market Snapshot
8.5.1. Brazil Leather Goods Market
8.5.2. Mexico Leather Goods Market
8.5.3. Rest of Latin America Leather Goods Market
8.6. Rest of The World Leather Goods Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Adidas AG
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Nike. Inc.
9.2.3. Puma SE
9.2.4. Fila Inc.
9.2.5. New balance Athletics Inc.
9.2.6. Samsonite International S.A
9.2.7. VIP Industries Ltd.
9.2.8. Timberland LLC
9.2.9. Knoll Inc,
9.2.10. American leather holdings, LLC
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.
Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.
24x7 Chat Support plus
free analyst hours with every purchase
Our 360-degree approach of market study, our research methods leave stones unturned.
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We offer wide range of services including Syndicated Reports, Customized Reports, Competitive Intelligence and others.
